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L I T E R A T U R E  H I G H L I G H T S
NEURORADIOLOGY
Selected abstracts and commentary
COMMENTARY
Technological developments have revolutionised the field of neuroradiology. Magnetic resonance imaging, multi-detector
row computerised tomography and rotational angiography have all contributed significantly not only in detecting disease
but also in  helping us better understand the processes that lead to the causation of these diseases.  Technological
developments are not limited to imaging alone, but also have significant impact in the field of neuro-intervention. Stroke
intervention and therapy is now becoming the norm, even in Pakistan.
A neuroradiology literature review covering the last three months reflects this. MR spectroscopy has the potential of
revealing the biochemical make up of lesions. Although its application in diffuse brain diseases such as ischaemic
encephalopathy is defined, its role in focal brain lesions has yet to be established. A systematic review carried out by
Hollingworth et al has tried to address part of this issue. They concluded that although results in terms of characterising
brain tumours were promising, the evidence was still not sufficient.
The role of interventional neuroradiology is growing, especially in the field of stroke management. Data from part 1 of the
MERCI trail has been published. These results indicate that mechanical thrombolysis may be effective and safe even when
IV thrombolysis has failed. Staying with the subject of intervention, two papers by Rooij et al testify to the procedural safety
of coiling, both in ruptured and unruptured aneurysms.
Of particular local interest will be the article by Wattjes et al. While low field-strength MR scanners are sprouting all over
the place and claiming to provide as good a diagnostic image as medium field-strength rivals, this article highlights there
are important deficiencies of these machines. The comparison reported is between 1.5 and 3 Tesla scanners, but the data
can very easily be extrapolated to 0.3 and 1.5 T machines as well. As they say in brain MR, what you don't see may be as
important as what you see.
Kaskarelis and co-workers suggest that inferior petrosal sinus sampling be part of every work up for Cushing's syndrome.
This may not be feasible in our setting but nevertheless highlights the role of this technique in equivocal cases.
And finally something that only radiologists seem to worry about: radiation dose. Even before the advent of MDCT (multi-
detector CT), diagnostic imaging was the single largest contributor to the radiation burden on society. This is set to
increase manifold with MDCT routinely using over 200 slices per examination. Cohnen et al's article is slightly reassuring as
their calculated dose is only (!) 9.5 mSv. (Keep in mind that the average CT of the head done on a single slice machine
gives a dose of about 1.5 mSv). Information obtained from the MDCT image is considerably better than from standard CT
of the head, but there is a price to pay and this price is not just financial.
Zafar Sajjad
Associate Professor of Radiology
Aga University Hospital
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W. Hollingwortha, L.S. Medinac, R.E. Lenkinskid, D.K. Shibataa, B. Bernalc, D. Zurakowskie, B. Comstockb and
J.G. Jarvika
a Departments of Radiology, University of Washington, Seattle, Wash; b General Internal Medicine, University of Washington, Seattle, Wash; c Department of
Radiology, Miami Children's Hospital, Miami, Fla; d Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Mass; e Departments of Orthopaedic
Surgery and Biostatistics, Harvard Medical School, Boston, Mass 
American Journal of Neuroradiology 27:1404-1411, August 2006
BACKGROUND AND PURPOSE: Proton MR spectroscopy
(1H-MR spectroscopy) is a potentially useful adjunct to
anatomic MR imaging in the characterization of brain tumors.
We performed an updated systematic review of the evidence. 
METHODS: We employed a standardized search strategy to
find studies published during 2002-2004. We reviewed
studies measuring diagnostic accuracy and diagnostic,
therapeutic, or health impact of 1H-MR spectroscopy. We
abstracted information on study design, 1H-MR spectroscopy
technique, and methodologic quality. We categorized studies
into 5 subgroups: (1) metastasis versus high-grade tumor;
(2) high-versus low-grade tumor; (3) recurrent tumor versus
radiation necrosis; (4) tumor extent; and (5) tumor versus
non-neoplastic lesion. R E S U L T S : We identified 26 studies
evaluating diagnostic performance, diagnostic impact, or
therapeutic impact. No articles evaluated patient health or
cost-effectiveness. Methodologic quality was mixed; most
used histopathology as the reference standard but did not
specify blinded interpretation of histopathology. One large
study demonstrated a statistically significant increase in
diagnostic accuracy for indeterminate brain lesions from
55%, based on MR imaging, to 71% after analysis of 1H-MR
spectroscopy. Several studies have found that 1H-MR
spectroscopy is highly accurate for distinguishing high- and
low-grade gliomas, though the incremental benefit of 1H-MR
spectroscopy in this setting is less clear. Interpretation for
the other clinical subgroups is limited by the small number of
studies. C O N C L U S I O N : The current evidence on the
accuracy of 1H-MR spectroscopy in the characterization of
brain tumors is promising. However, additional high-quality
studies are needed to convince policy makers. We present
guidelines to help focus future research in this area.
Correspondence to William Hollingworth, PhD, Department of Radiology, Box 359960, 325 Ninth Ave, Seattle, WA 98104-2499; e-mail: willh@u.washington.edu
A SYSTEMATIC LITERATURE REVIEW OF MAGNETIC RESONANCE SPECTROSCOPY FOR THE
CHARACTERIZATION OF BRAIN TUMORS 
SAFETY OF MECHANICAL THROMBECTOMY AND INTRAVENOUS TISSUE PLASMINOGEN
ACTIVATOR IN ACUTE ISCHEMIC STROKE. RESULTS OF THE MULTI MECHANICAL EMBOLUS
REMOVAL IN CEREBRAL ISCHEMIA (MERCI) TRIAL, PART I 
W.S. Smith for the Multi MERCI Investigators 
Correspondence to Wade S. Smith, MD, PhD, Department of Neurology, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143-0114 
American Journal of Neuroradiology 27:1177-1182, June-July 2006
B A C K G R O U N D : The MERCI (Mechanical Embolus Removal in
Cerebral Ischemia) trial reported efficacy of the Merci Retriever
for opening intracranial vessels in patients ineligible for
intravenous (IV) tissue plasminogen activator (tPA). Patients
who receive IV tPA but do not recanalize may also benefit from
thrombectomy, but the revascularization efficacy and safety of
this strategy has not been reported.  M E T H O D S : Multi MERCI
is an ongoing international, multicenter, prospective, single-
arm trial of patients with large vessel stroke treated within 8
hours of symptom onset. Patients were enrolled who had
received IV tPA but did not recanalize or who were ineligible for
IV tPA. Primary outcome was vascular recanalization
(Thrombolysis in Myocardial Infarction [TIMI] score II/III) and
safety. R E S U L T S : One hundred eleven patients received the
thrombectomy procedure. Mean age ± SD was 66.2 ± 17.0
years, and baseline National Institutes of Health Stroke Scale
(NIHSS) score was 19 ± 6.3. Thirty patients (27%) received IV
tPA before intervention. Treatment with the Retriever alone
resulted in successful recanalization in 60 of 111 (54%)
treatable vessels and in 77 of 111 (69%) after adjunctive
therapy (IA tPA, mechanical). Symptomatic intracranial
hemorrhage (ICH) occurred in 10 of 111 (9.0%). Clinically
significant procedural complications occurred in 5 of 111
(4.5%) patients. The symptomatic ICH rate was 2 of 30 (6.7%)
in patients pretreated with IV tPA and 8 of 81 (9.9%) in those
without (P > .99). C O N C L U S I O N S : Mechanical thrombectomy
after IV tPA seems as safe as mechanical thrombectomy
alone. Mechanical thrombectomy with both first- and second-
generation Merci devices is efficacious in opening intracranial
vessels during acute ischemic stroke in patients who are either
ineligible for IV fibrinolytic therapy or have failed IV fibrinolytic
t h e r a p y .
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PROCEDURAL MORBIDITY AND MORTALITY OF ELECTIVE COIL TREATMENT OF
UNRUPTURED INTRACRANIAL ANEURYSMS 
W.J. van Rooija and M. Sluzewskia
aDepartment of Radiology, St. Elisabeth Ziekenhuis, Tilburg, The Netherlands 
Correspondence to Willem Jan van Rooij, MD, PhD, Department of Radiology, St. Elisabeth Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, The Netherlands
e-mail: radiol@knmg.nl
American Journal of Neuroradiology 27:1678-1680, September 2006
BACKGROUND AND PURPOSE: To report morbidity,
mortality, and angiographic results of elective coiling of
unruptured intracranial aneurysms. METHODS: In a 10-year
period, 176 unruptured aneurysms in 149 patients were
electively treated with detachable coils. Seventy-nine
aneurysms were additional to another ruptured aneurysm but
were coiled more than 3 months after subarachnoid
hemorrhage, 59 aneurysms were incidentally discovered and
38 aneurysms presented with symptoms of mass effect.
Mean size of the 176 unruptured aneurysms was 10.6 mm
(median, 8 mm; range, 2-55 mm). One hundred thirteen
aneurysms (64%) were small (<10 mm), 44 aneurysms
(25%) were large (10-25 mm), and 19 aneurysms (11%)
were giant (25-55 mm). Thirty wide-necked aneurysms
(17%) were coiled with the aid of a supporting device.
R E S U L T S : Procedural mortality of coiling was 1.3% (2 of
149; 95% confidence interval [CI], 0.7-5.1%), and morbidity
was 2.6% (4 of 149, 95% CI, 0.8-7.0%). The 4 patients
with permanent morbidity were independent (GOS 4). Initial
aneurysm occlusion  was complete (100%) in 132
aneurysms, nearly complete (90%-98%) in 36 aneurysms,
and incomplete (60%-85%) in 8 aneurysms. Six-month
follow-up angiography was available in 132 patients with
154 coiled aneurysms (87.5%); partial reopening occurred
in 25, mainly large and giant aneurysms (16.2%). Additional
coiling was performed in 22 aneurysms and additional
parent vessel occlusion in 1 aneurysm. There were no
complications of additional treatments. C O N C L U S I O N :
Elective coiling of unruptured intracranial aneurysms has low
procedural mortality and morbidity. For the management of
unruptured aneurysms, endovascular treatment should be
considered.
PROCEDURAL COMPLICATIONS OF COILING OF RUPTURED INTRACRANIAL ANEURYSMS:
INCIDENCE AND RISK FACTORS IN A CONSECUTIVE SERIES OF 681 PATIENTS 
W.J. van Rooija, M. Sluzewskia, G.N. Beuteb and P.C. Nijssenc
a Department of Radiology, St Elisabeth Ziekenhuis Tilburg, The Netherlands; b Department of Neurosurgery, St Elisabeth Ziekenhuis Tilburg, The Netherlands; 
c Department of Neurology, St Elisabeth Ziekenhuis Tilburg, The Netherlands 
Correspondence to W.J. van Rooij, MD, PhD, Department of Radiology, St Elisabeth Ziekenhuis, Hilvarenbeekseweg 60, 5022 GC Tilburg, The Netherlands; e-mail: radiol@knmg.nl
American Journal of Neuroradiology 27:1498-1501, August 2006
BACKGROUND AND PURPOSE: To report the incidence of
procedural complications of coiling of ruptured intracranial
aneurysms leading to permanent disability or death in a
consecutive series of 681 patients and to identify risk factors
for these events. PATIENTS AND METHODS: B e t w e e n
January 1995 and July 2005, 681 consecutive patients with
ruptured intracranial aneurysms were treated with detachable
coils. Procedural complications (aneurysm rupture or
thromboembolic) of coiling leading to death or neurologic
disability at the time of hospital discharge were recorded. For
patients with procedural complications, odds ratios (OR) with
corresponding 95% confidence intervals (CI) were calculated
for the following patient and aneurysm characteristics:
patient age and sex, use of a supporting balloon, aneurysm
location, timing of treatment, clinical condition at the time of
treatment, and aneurysm size. R E S U L T S : P r o c e d u r a l
complications occurred in 40 of 681 patients (5.87%; 95%
CI, 4.2% to 7.9%), lead ing to death in 18 patients
(procedural mortality, 2.6%; 95% CI, 1.6% to 4.2%) and to
disability in 22 patients (procedural morbidity, 3.2%; 95% CI,
2.0% to 4.9%). There were 8 procedural ruptures and 32
thromboembolic complications. The use of a temporary
supporting balloon was the only significant risk factor (OR,
5.1; 95% CI, 2.3 to 15.3%) for the occurrence of procedural
complications. CONCLUSION: Procedural complication rate
of coiling of ruptured aneurysms leading to disability or death
is 5.9%. In this series, the use of a temporary supporting
balloon in the treatment of wide-necked aneurysms was the
only risk factor for the occurrence of complications. 
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Correspondence to: Mike Peter Wattjes, MD, Department of Radiology and Neuroradiology, University Hospital of Bonn, Sigmund-Freud-Str 25, D-53105 Bonn, Germany; 
e-mail: mike.wattjes@ukb.uni-bonn.de
DOES HIGH-FIELD MR IMAGING HAVE AN INFLUENCE ON THE CLASSIFICATION OF
PATIENTS WITH CLINICALLY ISOLATED SYNDROMES ACCORDING TO CURRENT DIAGNOSTIC
MR IMAGING CRITERIA FOR MULTIPLE SCLEROSIS? 
M.P. Wattjesa, M. Harzheimb, C.K. Kuhla, J. Giesekea, S. Schmidtb, L. Klotzb, T. Klockgetherb, H.H. Schilda and
G.G. Lutterbeya
a Department of Radiology/Neuroradiology, University Hospital of Bonn, Bonn, Germany, b Department of Neurology, University Hospital of Bonn, Bonn, Germany
American Journal of Neuroradiology 27:1794-1798, September 2006
BACKGROUND AND PURPOSE: Current MR imaging criteria
for multiple sclerosis (MS) do not specify the magnetic field
strength. The aim of this study was to investigate whether
different MR imaging field strengths, specifically high-field
MR imaging, have an impact on the classification of patients
with c linically isolated syndromes suggest ive of MS,
according to MR imaging and diagnostic criteria. METHODS:
In a prospective intraindividual comparative study, we
examined 40 patients with clinically isolated syndromes (CIS)
consecutively with a 1.5T and 3T MR imaging system,
including axial sections of T2 turbo sp in-echo, f luid-
attenuated inversion recovery, and T1 spin-echo, before and
after injection of gadolinium-diethylene-triaminepentaacetic
acid. Constant resolution parameters were used for both field
strengths. High-signal-intensity white matter lesions with a
size of >3 mm were counted and categorized according to
the ir anatomic location in inf ratentorial , callosal ,
juxtacortical, periventricular, and other white matter areas.
Assessment of the fulf i l led Barkhof MR imaging and
McDonald diagnostic criteria was made separately for both
field strengths in every patient. R E S U L T S : Eleven patients
fulfilled more MR imaging criteria at 3T. Two of these
patients fulfilled the criterion of dissemination in space (DIS)
according to the first definition of McDonald criteria, which is
based on imaging criteria alone. Another patient had DIS
only at 3T, according to the second definition of the
McDonald criteria including CSF parameters. CONCLUSION:
MR field strength, specifically high-field MR imaging, has a
substantial influence on the classification of patients with CIS
accord ing to imaging and a mi ld inf luence on the
classification according diagnostic criteria for MS, leading to
consequences for  prognostic  classif ication, imaging
guidelines, and clinical trials. 
BILATERAL INFERIOR PETROSAL SINUSES SAMPLING IN THE ROUTINE INVESTIGATION OF
CUSHING'S SYNDROME: A COMPARISON WITH MRI
Ioannis S. Kaskarelis1, Emmanouela G. Tsatalou1, Stylianos V. Benakis1, Katerina Malagari2, Ioannis Komninos3,
Dimitra Vasiliadou3, Stylianos Tsagarakis3 and Nikolaos Thalassinos3
1 Department of Radiology, Evangelismos General Hospital, 11 Amasias St., Athens, Greece 11634; 2 Department of Radiology, University of Athens, Athens, Greece;
3 Department of Endocrinology, Evangelismos General Hospital, Athens, Greece. 
AJR 2006; 187:562-570
O B J E C T I V E : Identifying the cause of Cushing's syndrome
(CS) is a perplexing issue. Bilateral inferior petrosal sinuses
sampling (BIPSS) is an invasive and elaborate but
established procedure in distinguishing Cushing's disease
(CD) from ectopic adrenocorticotropic hormone (ACTH)
syndrome. We compare the diagnostic performance of BIPSS
and MRI in detecting an ACTH-secreting source, and we
suggest the diagnostic protocol that we found beneficial for
the management of patients with CS. MATERIALS AND
METHODS: Seventy-eight consecutive patients with CS were
included. All patients underwent biochemical investigation
and pituitary MRI. Consequently, patients were routinely
referred for  BIPSS; 25 rece ived st imulation with
corticotropin-releasing hormone (CRH) and 53 with CRH and
desmopressin. The diagnosis of CD was established on the
basis of complementary biochemical, imaging, and BIPSS
criteria. The diagnostic performances of BIPSS and MRI were
calculated for patients with final diagnosis. RESULTS: A final
diagnosis was available for 54 patients (46 CD confirmed,
five ectopic confirmed, three adrenals). No (known) patient
was misclassified based on our suggested diagnostic criteria.
MRI rendered 25 false-negatives and two false-positives
(incidentalomas). Successful BIPSS yielded two false-
negatives and three false-positives (adrenals). The calculated
accuracy for detecting a pituitary source of ACTH was 50%
and 88% for MRI and successful BIPSS, respectively. 
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Correspondence to: Priv.-Doz. Dr. M. Cohnen, Institute of Diagnostic Radiology, University Hospital, MNR-Klinik, Heinrich-Heine-University, Moorenstr. 5, 40225 Düsseldorf, Germany;
e-mail: cohnen@med.uni-duesseldorf.de
RADIATION EXPOSURE OF PATIENTS IN COMPREHENSIVE COMPUTED TOMOGRAPHY OF
THE HEAD IN ACUTE STROKE
M. Cohnena, H.-J. Wittsacka, S. Assadia, K. Muskallab, A. Ringelsteina, L.W. Polla, A. Saleha and U. Möddera
a Institute of Diagnostic Radiology, University Hospital Düsseldorf, Düsseldorf, Germany, b Department of Radiation Oncology, University Hospital Düsseldorf,
Düsseldorf, Germany
American Journal of Neuroradiology 27:1741-1745, September 2006
BACKGROUND AND PURPOSE: To assess patient radiation
exposure in comprehensive stroke imaging using
multidetector row CT (MDCT) combining standard CT of the
head, cerebral perfusion (CTP), and CT angiography (CTA)
studies. METHODS: Examination protocols for CT and CTA of
cerebral and cervical vessels, as well as CTP were simulated
using a Somatom Sensation Cardiac 64. Effective doses
were derived from measurements with the use of lithium-
fluoride thermoluminescent dosimeters (LiF-TLD) at several
organ sites using an Alderson-Rando phantom. R E S U L T S :
LiF-TLD measurements resulted in effective doses of 1.7
mSv for CT, 1.9 mSv for CTA of intracranial vessels, and 2.8
mSv for CTA of cervical vessels, respectively. Depending on
examination parameters, effective doses varied between 1.1
and 5.0 mSv for cerebral CTP. For CTP, local doses in the
area of the primary beam ranged between 114 and 444
mGy. CONCLUSIONS: Comprehensive stroke imaging may
result in up to 9.5 mSv with possible local doses of 490
mGy. Although critical doses for organ damage (eg, cataract
formation or hair loss) are not reached, physicians need to
be aware of possible radiation induced sequelae particularly
in repetitive examinations. 
C O N C L U S I O N : MRI is  of  only  l imi ted diagnostic
performance, while BIPSS is the most accurate way to
establish the d iagnosis of CD. The rout ine use of a
multimodality diagnostic approach including BIPSS, MRI, and
biochemica l tests  is  suggested to avo id the risk of
mismanagement for patients with CS.
